{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:30:16Z","timestamp":1789587016588,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejmech.2022.114330","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:08:05Z","timestamp":1649070485000},"page":"114330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Design, synthesis and preclinical evaluation of bio-conjugated amylinomimetic peptides as long-acting amylin receptor agonists"],"prefix":"10.1016","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-0038","authenticated-orcid":false,"given":"Raymond J.","family":"Patch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Edavettal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Macielag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette J.","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Rives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Hinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Libiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songmao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jey","family":"Jeyaseelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamina M.","family":"Rangwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Hornby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.ejmech.2022.114330_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jcb.240550006","article-title":"Molecular physiology of the islet amyloid polypeptide (IAPP)\/amylin gene in man, rat, and transgenic mice","volume":"55","author":"Hoppener","year":"1994","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ejmech.2022.114330_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.physbeh.2011.02.015","article-title":"Amylinergic control of food intake in lean and obese rodents","volume":"105","author":"Boyle","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejmech.2022.114330_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/pr.115.010629","article-title":"Amylin: pharmacology, physiology, and clinical potential","volume":"67","author":"Hay","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2022.114330_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(94)90388-3","article-title":"In\u00a0vitro autoradiographic localization of amylin binding sites in rat brain","volume":"62","author":"Sexton","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2022.114330_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/mol.56.1.235","article-title":"Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product","volume":"56","author":"Christopoulos","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114330_bib6","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/bph.13496","article-title":"Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development","volume":"173","author":"Bower","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114330_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M","article-title":"Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin","volume":"37","author":"Young","year":"1996","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2022.114330_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/vhrm.2006.2.3.203","article-title":"Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes","volume":"2","author":"Pullman","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ejmech.2022.114330_bib9","doi-asserted-by":"crossref","first-page":"E620","DOI":"10.1152\/ajpendo.00217.2007","article-title":"Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study","volume":"293","author":"Smith","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2022.114330_bib10","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/dc08-0029","article-title":"Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity","volume":"31","author":"Smith","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2022.114330_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/187152208787169189","article-title":"Amylin-based pharmacotherapy \u2013 past, present & future","volume":"8","author":"Roth","year":"2008","journal-title":"Immunol. Endocr. Metab. Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114330_bib12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1463-1326.2011.01465.x","article-title":"Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide","volume":"13","author":"Mack","year":"2011","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejmech.2022.114330_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138803","article-title":"Monoconjugation of human amylin with methylpolyethyleneglycol","volume":"10","author":"Sisnande","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114330_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.peptides.2019.04.004","article-title":"BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats","volume":"114","author":"Nascimento","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.ejmech.2022.114330_bib15","doi-asserted-by":"crossref","first-page":"617400","DOI":"10.3389\/fendo.2020.617400","article-title":"Amylin and calcitonin: potential therapeutic strategies to reduce body weight and liver fat","volume":"11","author":"Mathiesen","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2022.114330_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/jpet.121.000567","article-title":"AM833 is a novel agonist of calcitonin family G protein-coupled receptors: pharmacological comparison to six selective and non-selective agonists","volume":"377","author":"Fletcher","year":"2021","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2022.114330_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/jpet.119.257576","article-title":"The dual amylin and calcitonin receptor agonist KBP-088 induces weight loss and improves insulin sensitivity superior to chronic amylin therapy","volume":"370","author":"Larsen","year":"2019","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2022.114330_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/jpet.119.263723","article-title":"The dual amylin and calcitonin receptor agonist, KBP-066, induces an equally potent weight loss across a broad dose range while higher doses may further improve insulin action","volume":"373","author":"Sonne","year":"2020","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2022.114330_bib19","doi-asserted-by":"crossref","first-page":"1794687","DOI":"10.1080\/19420862.2020.1794687","article-title":"Conjugation of a peptide to an antibody engineered with free cysteines dramatically improves half-life and activity","volume":"12","author":"Camacho","year":"2020","journal-title":"mAbs"},{"key":"10.1016\/j.ejmech.2022.114330_bib20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cmet.2019.01.017","article-title":"A\u00a0long-acting PYY3-36 analog mediates robust anorectic efficacy with minimal emesis in nonhuman primates","volume":"29","author":"Rangwala","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2022.114330_bib21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-3565(25)24459-7","article-title":"Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31, Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands,","volume":"272","author":"Dumont","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2022.114330_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cne.903060107","article-title":"Subregional topography of capillaries in the dorsal vagal complex of rats: II. Physiological properties","volume":"306","author":"Gross","year":"1991","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.ejmech.2022.114330_bib23","unstructured":"L. Schaeffer, T. Kruse, H. Thoegersen, Polypeptides, U.S. Patent 8,741,836."},{"key":"10.1016\/j.ejmech.2022.114330_bib24","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1021\/jm401418s","article-title":"Bifunctional PEGylated exenatide-amylinomimetic hybrids to treat metabolic disorders: an example of long-acting dual hormonal therapeutics","volume":"56","author":"Sun","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114330_bib25","unstructured":"Lys(dPEG12-Mal) Refers to a Lysine Residue in which the Side Chain \u03b5-amine is Derivatized with {N-maleimido-(CH2)2CONH(CH2)2[(CH2)2O]12 CO}."},{"key":"10.1016\/j.ejmech.2022.114330_bib26","unstructured":"C. Sun, M.P. Samant, S. Neravetla, Amylin peptides and derivatives and uses thereof, Int. Patent Appl. WO 2012\/162542."},{"key":"10.1016\/j.ejmech.2022.114330_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.xphs.2015.11.037","article-title":"Physical and chemical stability of antibody drug conjugates: current status,","volume":"105","author":"Ross","year":"2016","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ejmech.2022.114330_bib28","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1021\/acs.analchem.8b00411","article-title":"LC\/MS\/MS bioanalysis of protein\u2212drug conjugates\u2212the importance of incorporating succinimide hydrolysis products","volume":"90","author":"Shi","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2022.114330_bib29","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0006-2952(87)90070-0","article-title":"Reversibility of disulfide formation. Comparison of chemical and enzyme-mediated reduction of penicillamine and captopril disulfides","volume":"36","author":"Drummer","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114330_bib30","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1073\/pnas.86.24.9662","article-title":"Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus","volume":"86","author":"Roberts","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2022.114330_bib31","first-page":"E827","article-title":"Dissociation of the effects of amylin on osteoblast proliferation and bone resorption","volume":"274","author":"Cornish","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejmech.2022.114330_bib32","doi-asserted-by":"crossref","first-page":"304513","DOI":"10.1155\/2008\/304513","article-title":"Disturbed \u03b1-cell function in mice with \u03b2-cell specific overexpression of human islet amyloid polypeptide","volume":"2008","author":"Ahr\u00e9n","year":"2008","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.ejmech.2022.114330_bib33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0196-9781(91)90148-I","article-title":"Amylin decreases food intake in mice","volume":"12","author":"Morley","year":"1991","journal-title":"Peptides"},{"issue":"suppl 1","key":"10.1016\/j.ejmech.2022.114330_bib34","first-page":"333A","article-title":"Synergistic effect of amylin and cholecystokinine octapeptide on food intake in mice","volume":"45","author":"Bhavsar","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2022.114330_bib35","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1464-5491.2004.01319.x","article-title":"Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial","volume":"21","author":"Ratner","year":"2004","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ejmech.2022.114330_bib36","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.26.3.784","article-title":"Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial","volume":"26","author":"Hollander","year":"2003","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114330_bib37","first-page":"5","article-title":"Efficacy and safety of AM833 for weight loss: a dose-finding trial in adults with overweight\/obesity","volume":"28","author":"Lau","year":"2020","journal-title":"Oral Abstracts. Obesity"},{"key":"10.1016\/j.ejmech.2022.114330_bib38","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(21)00845-X","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomized, controlled phase 1b trial","volume":"397","author":"Enebo","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.114330_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MED.0000000000000716","article-title":"Long-acting amylin analogues for the management of obesity","volume":"29","author":"Mathiesen","year":"2022","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.ejmech.2022.114330_bib40","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.1021\/ja9010095","article-title":"Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy","volume":"131","author":"Nanga","year":"2009","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114330_bib41","doi-asserted-by":"crossref","first-page":"12689","DOI":"10.1021\/bi8014357","article-title":"Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy","volume":"47","author":"Nanga","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2022.114330_bib42","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1074\/jbc.M115.713628","article-title":"Calcitonin and amylin receptor peptide interaction mechanisms. Insights into peptide-binding modes and allosteric modulation of the calcitonin receptor by receptor activity-modifying proteins","volume":"291","author":"Lee","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114330_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0167-0115(94)90142-2","article-title":"Isolation and sequence determination of two N-terminal fragments of islet amyloid polypeptide in rat pancreas","volume":"49","author":"Miyazato","year":"1994","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejmech.2022.114330_bib44","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.tibs.2008.05.001","article-title":"Class-B GPCR activation: is ligand helix-capping the key?","volume":"33","author":"Neumann","year":"2008","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2022.114330_bib45","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.1152\/ajpendo.2000.279.4.E730","article-title":"Systemic administration of a novel octapeptide, amylin-(1\u20138), increases bone volume in male mice","volume":"279","author":"Cornish","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2022.114330_bib46","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.bmc.2012.02.030","article-title":"Synthesis and evaluation of disulfide bond mimetics of amylin-(1\u20138) as agents to treat osteoporosis","volume":"20","author":"Kowalczyk","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114330_bib47","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1016\/j.bmc.2012.08.053","article-title":"How to blast osteoblasts? Novel dicarba analogues of amylin-(1\u20138) to treat osteoporosis","volume":"20","author":"Kowalczyk","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114330_bib48","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nature05143","article-title":"Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism","volume":"443","author":"Shen","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114330_bib49","series-title":"Optimization in Drug Discovery. Methods in Pharmacology and Toxicology","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-1-62703-742-6_27","article-title":"Drug, lipid and acylcarnitine profiling using dried blood spot (DBS) technology in drug discovery","author":"Lang","year":"2014"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342200232X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342200232X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:43:22Z","timestamp":1759329802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342200232X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":49,"alternative-id":["S022352342200232X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114330","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and preclinical evaluation of bio-conjugated amylinomimetic peptides as long-acting amylin receptor agonists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114330"}}